Bridging traditional formulation wisdom with high-performance analytics, toxicity profiling, and GLP/GMP batch-to-batch compliance.
ODM Study and evaluation of the potency of the botanical active ingredient(s) from different seasons and different origins
Explore Service
ODM Clinic study (Phase1 - Phase 4) Manufacturer, Suppliers
Explore Service
China Screening of the active ingredient(s) of plants Manufacturer, Manufacturers
Explore Service
China Establishment of analysis methods of active ingredient(s) Supplier, Suppliers
Explore Service
OEM Animal study Supplier, Suppliers
Explore Service
OEM In Vitro Test /Research Service Manufacturers, Suppliers
Explore Service
Botanical Active Screening & High-Throughput Bioactivity Profiling
Explore Service
Natural Material & Origin Potency Scientific Evaluation
Explore ServiceDeciphering multi-target phytochemistry via multi-omics, fingerprinting algorithms, and systematic extraction engineering.
Conventional herbal formulations historically suffered from compositional variations caused by altitude, soil microbiome, and seasonal harvest shifts. As an experienced ODM manufacturer, MedGence converts empirical remedies into standardized medical-grade assets by tracking active chemical markers—including flavonoids, saponins, and alkaloids—across verified provenance databases.
Reliability requires transparent identification. Utilizing HPLC, HPTLC, and GC-MS fingerprints, our laboratory establishes multi-dimensional similarity analysis. This ensures that every commercial production lot reflects the identical molecular profile validated in initial safety, pharmacodynamics, and clinical trials.
Under our contract research and CDMO framework, client intellectual property is shielded by strict NDAs and operational compartmentalization. Our cleanroom facilities run pilot-scale and commercial campaigns without risking cross-contamination or leaking core formula parameters.
Harnessing geo-authentic botanical raw materials alongside deep industrial-scale extraction clusters.
Direct sourcing networks across primary Chinese eco-zones yield raw botanicals cultivated under Good Agricultural and Collection Practices (GACP), securing optimal secondary metabolite density before extraction.
Our collaborative industrial base integrates automated counter-current extraction, supercritical CO2 fluid fractionation, and low-temperature membrane concentration to prevent thermal degradation of delicate bioactives.
Seamlessly scale from benchtop feasibility studies to 100 kg pilot runs and multi-ton commercial orders. Production capabilities bridge solid, liquid, capsule, and customized granule requirements effortlessly.
Rigorous screening for heavy metals (ICP-MS), pesticide residues (GC-MS/MS), aflatoxins, and microbiological counts ensures total compliance with international pharmacopeial limits.
Consult with our lead scientists to determine bio-screening timelines, pilot specs, and target market documentation.
Eliminate dossier rejection risks via region-specific standardizations designed for the US FDA, EU EMA, and ASEAN bodies.
We provide full analytical datasets, residual solvent assays (USP <467>), elemental impurity analyses (USP <232>), and safety substantiations required for New Dietary Ingredient (NDI) filings and Self-Affirmed GRAS dossiers.
Technical support for Traditional Herbal Medicinal Products (THMPD) pathways, complete with documented bibliographic safety evidence, validated extraction solvents, and stability studies adhering to ICH Q1A guidelines.
Localized formulation adaptation accommodating regional raw material positive lists, Halal and Kosher certified production flows, and custom physicochemical parameter optimizations.
Designed around the rigorous vendor qualification benchmarks of multinational healthcare enterprises.
Complete batch records, Certificates of Analysis (COA), audit trails, and open verification facilities that satisfy QA/QC corporate compliance protocols.
Mitigate agricultural shocks via dual-sourcing storage networks and systematic harvest forecast systems, avoiding global stockout risks.
Agile production lines support custom trial batches starting from tens of kilograms to continuous multi-metric ton container shipments.
From botanical active compound discovery to Phase I–IV clinical validation and registered finished packaging, we condense the supply ecosystem.
Translating purified compounds and multi-herb formulations into commercially successful delivery formats.
High-purity botanical powders, spray-dried extracts, and liquid concentrates standardized by HPLC marker assays.
Tablets, coated caplets, enteric-coated capsules, and effervescent delivery formats engineered for optimal dissolution rates.
Oral solutions, herbal syrups, sublingual tinctures, and standardized concentrated extracts stabilized against phase separation.
Water-dispersible and oil-soluble plant fractions tested for transdermal penetration, anti-oxidation, and anti-inflammatory activity.
Instant dissolving herbal granules processed through fluidized-bed granulation, ensuring rapid bioavailability.
Emerging research methodologies shaping next-generation phyto-pharmaceutical developments.
Integrating in silico molecular docking algorithms with expansive phytochemistry libraries to predict receptor binding dynamics, shortening initial screening from months to days.
Liposomal encapsulation, solid lipid nanoparticles, and phytosomes engineered to resolve the inherent poor water solubility and low enterocyte permeability of key herbal molecules.
Closed-loop, green extraction processes deploying bio-based solvents, enzymatic pre-treatments, and zero-discharge solvent recycling protocols to fulfill global ESG directives.
Decades of contract research and commercial manufacturing partnerships with prominent pharmaceutical conglomerates.












Essential guidance for pharmaceutical R&D directors, formulation specialists, and international sourcing teams.
Explore our complete service and supply spectrum ready for immediate deployment.
ODM Study and evaluation of the potency of the botanical active ingredient(s) from different seasons and different origins
Request Study Data
ODM Clinic study (Phase1 - Phase 4) Manufacturer, Suppliers
Request Study Data
China Screening of the active ingredient(s) of plants Manufacturer, Manufacturers
Request Study Data
China Establishment of analysis methods of active ingredient(s) Supplier, Suppliers
Request Study Data
OEM Animal study Supplier, Suppliers
Request Study Data
OEM In Vitro Test /Research Service Manufacturers, Suppliers
Request Study Data
High-Yield Active Ingredient Extraction & Fractionation
Request Study Data
Botanical Origin Standard Establishing & QC Optimization
Request Study Data